C2N DIAGNOSTICS
C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration. They formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch.com). They reside at the Center for Emerging Technologies in St. Louis.
C2N DIAGNOSTICS
Social Links:
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.c2ndiagnostics.com
Total Employee:
11+
Status:
Active
Contact:
314-633-1884
Email Addresses:
[email protected]
Total Funding:
22.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Google Cloud Google Cloud Iowa Squarespace Hosted Proofpoint URL Defense
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
Turnstone Biologics
Turnstone Biologics is a privately-held clinical stage biotech company.
CareDx
CareDx is a novel molecular diagnostics company.
Current Employees Featured
Founder
Investors List
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - C2N Diagnostics
GHR Foundation
GHR Foundation investment in Venture Round - C2N Diagnostics
Official Site Inspections
http://www.c2ndiagnostics.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "C2N Diagnostics"
C2N Diagnostics
C₂N is a specialty diagnostics company providing exceptional laboratory services and products in the field of brain health. C₂N’s high-resolution mass spectrometry-based biomarker products …See details»
C2N Diagnostics - Crunchbase Company Profile
C2N Diagnostics is a specialty diagnostics company focused on providing laboratory services and products in brain health with innovative technologies. …See details»
C2N DIAGNOSTICS, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for C2N DIAGNOSTICS, LLC of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
About (Copy) — C2N Diagnostics
Tim West, PhD VP, Research and Development. Dr. West obtained his PhD in molecular cell biology and neuroscience from Washington University. He conducted his graduate thesis …See details»
C2N Diagnostics Overview | SignalHire Company Profile
C2N Diagnostics is a private company that has been in the industry for 18 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is …See details»
C2N Diagnostics - LinkedIn
C2N Diagnostics Biotechnology Research St Louis, Missouri 8,179 followers Fierce Medtech named C2N one of its Fierce 15 for 2020; "one of the most promising private companies in the industry.”See details»
C2N Diagnostics - Funding, Financials, Valuation & Investors
C2N Diagnostics is a specialty company focused on brain health and neurodegenerative diagnostics, advancing early detection solutions. New. Resources. ... How much funding has …See details»
C2N Diagnostics - PitchBook
C2N Diagnostics General Information Description. Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. The company provides precise, …See details»
C2N Diagnostics Company Profile - Office Locations, Competitors …
C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. It offers Precivity tests, blood tests that help …See details»
C2N Diagnostics - Contacts, Employees, Board Members
C2N Diagnostics is a specialty company focused on brain health and neurodegenerative diagnostics, advancing early detection solutions. ... Experience the new Crunchbase, powered …See details»
C2N Diagnostics - Overview, News & Similar companies - ZoomInfo
Apr 24, 2023 Who is C2N Diagnostics. C2N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation. C2N strives to provide exceptional laboratory …See details»
C2N Diagnostics | St. Louis MO - Facebook
C2N Diagnostics is honored to announce its partnership with The Michael J. Fox Foundation for Parkinson's Research. The initiative will focus on better understanding of the connections …See details»
Samsung to invest $10 million in US-based C2N Diagnostics
Mar 13, 2025 Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s disease diagnostics, …See details»
C2N Diagnostics - Overview, News & Similar companies - ZoomInfo
Who is C2N Diagnostics. C2N Diagnostics (www.c2ndiagnostics.com) was formed by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University Scho ol of …See details»
C2N Diagnostics | Alzheimer's Drug Discovery Foundation
Oct 1, 2024 C2N Diagnostics, LLC has established itself as a leading innovator in the field of high-performance blood biomarkers to aid in the early diagnosis of Alzheimer’s disease (AD). …See details»
C2N Diagnostics Partners with The Michael J. Fox Foundation to …
ST. LOUIS — Jan. 15, 2025 — A respected organization acclaimed for their groundbreaking work with neurological diseases, C2N Diagnostics, LLC, is partnering with The Michael J. Fox …See details»
Clinical Diagnostics — C2N Diagnostics
The Precivity™ tests are innovative new blood tests intended for use in patients with cognitive impairment. These tests aim to help healthcare providers determine the presence or absence …See details»
C2N Diagnostics and Unilabs Announce Global Partnership, …
Aug 6, 2024 LOUIS, MO. and GENEVA, SWITZERLAND — Aug. 7, 2024 — Unilabs (“Unilabs”), a leading international provider of diagnostic services, and C2N Diagnostics, LLC (“C2N”), a …See details»
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to …
Jan 28, 2025 Toronto Memory Program (TMP) is the first clinic in the country to offer the PrecivityAD2™ blood test from C2N Diagnostics, LLC (“C2N”). This blood test allows …See details»
Samsung Invests in C2N Diagnostics
Mar 12, 2025 Partnership to Expand C2N’s Commercial Scale and Innovation Pipeline. ST. LOUIS — March 13, 2025 — C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company …See details»